Keywords: GlaxoSmithKline, Patent infringement law suit, Roche, Genentech, Herceptin, Theravance, Relovair, Lung function, COPD

GlaxoSmithKline sues Roche/Genentech alleging Herceptin patent infringements; updates on Relovair Ph II development with Theravance

Article | 23 September 2010

Print This

UK pharmaceutical giant GlaxoSmithKline (LSE: GSK) has filed a law suit in the USA against Swiss drug major Roche (ROG. ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in